维普中文期刊产品整合服务
24篇 您的检索式:作者名="Dahle SE"
    题名 作者 年代 出处 被引量
1Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia显示文摘DAHLE SE CHOKKALINGAM AP GAO YT 2002J Urol2002,168,2:1
2Bodysize and ser- um levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia 显示文摘Dahle SE Chokkalingam AP Gao YT 2002J Urol2002,168,:1
3Hypoxia-inducible factor regulatesαtvβ3 integrin cell surface expression 显示文摘Cowden Dahl KD Robertson SE Weaver VM 2005Mol Biol Cell2005,16,14:1
4Leukotrienes and lipoxins : structures, biosynthesis, and biological effects显示文摘Samuelsson B Dahl~n SE Lindgren JA 1987Science1987,237,4819:1
5Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE):a randomized trial against atenolol显示文摘Dahl?f B Devereux RB Kjeldsen SE 0,,9311:1
6Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate 显示文摘Gyllfors P Dahle SE Kumlin M 2006J Allergy Clin Immunol2006,118,1:1
7Body size and serum levels ofinsulin and leptin in relation to the risk of benign prostatic hyperplasia显示文摘Dahle SE Chokkalingam AP Gao YT 0,,02:1
8The lipoxin receptor ALX:potent ligand-specific and stereoselective actions in vivo显示文摘Chiang N Serhan CN Dahlén SE 0,,03:1
9Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia 显示文摘Dahle SE Chokkalingam AP Gao YT 2002J Urol2002,168,2:1
10Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol显示文摘Dahlf B Devereux RB Kjeldsen SE 2002Lancet2002,359,:1
11Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia 显示文摘DAHLE SE ANAND P GAO YT 2002J Urol2002,168,2:1
12Electrical stimulation therapy and wound healing: where are we now? 显示文摘Rivkah IR Dahle SE 2011Adv Wound Care2011,1,6:1
13Hypoxia- inducible factor regulate av B 3 intergfin cell surface expression显示文摘Cowden Dahl KD Robertson SE Weaver VM 2005Mol Biol Cell2005,16,4:1
14Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia显示文摘Dahle SE Chokkalingam AP Gao YT 2002J Urol2002,168,2:1
15Asthma treatment guidelines meet the real world显示文摘Dahlén SE Dahlén B Drazen JM 0,,18:1
16Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia显示文摘Dahle SE Chokkalingam AP Gao YT 2002J Urol2002,168,2:1
17Treatment of asthma with antileukotrienes:first line or last resort therapy?显示文摘Dahl e n SE 2006Eur J Pharmacol2006,533,13:1
18Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia显示文摘Dahle SE Chokkalingam AP Gao YT 2002J Urol2002,168,2:1
19Catalytic partial oxidation of methane over Ni-, Co- and Fe-based catalysts显示文摘?se Slagtern Hendrick M Swaan Unni Olsbye Ivar M Dahl Claude Mirodatos 1998Catalysis Today1998,,2:1
20Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study(LITE):a randomized trial againt atenolol显示文摘Dahlf B Devereux RB Kjeldsen SE 2002Lancet2002,359,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费